BRK-B vs MRCC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MRCC exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic dividend payout ratio of 1111.11%. While the stock trades at a significant discount to book value (P/B 0.66), this is a classic value trap given the negative ROE (-2.86%) and a massive YoY revenue decline of 41.80%. The combination of negative profit margins and a 0/100 technical trend suggests a continuing downward trajectory with high risk of dividend cuts.
Compare Another Pair
Related Comparisons
BRK-B vs MRCC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Monroe Capital Corporation (MRCC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.